Sign In
The Oncology Pharma Inc. stock price gained 5.97% on the last trading day (Monday, 21st Jun 2021), rising from $33.68 to $35.69. During the day the stock fluctuated 8.47% from a day low at $34.01 to a day high of $36.89. The price has risen in 7 of the last 10 days and is up by 50.59% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 94 thousand more shares were traded than the day before. In total, 231 thousand shares were bought and sold for approximately $8.26 million.
The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $39.53 will give a strong buy signal and a trend shift could be expected.Given the current horizontal trend, you can expect Oncology Pharma Inc. stock with a 90% probability to be traded between $18.56 and $39.16 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
The Oncology Pharma Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.37 and $25.89. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 27, 2021, and so far it has fallen -10.21%. Further fall is indicated until a new bottom pivot has been found.
Oncology Pharma Inc. finds support from accumulated volume at $35.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.88 between high and low, or 8.47%. For the last week, the stock has had a daily average volatility of 17.00%.
The Oncology Pharma Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Oncology Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
Check full Oncology Pharma forecast and analysis here.